New York State Teachers Retirement System Purchases 4,387 Shares of Cigna Group $CI

New York State Teachers Retirement System increased its position in Cigna Group (NYSE:CI) by 2.1% during the 1st quarter, Holdings Channel.com reports. The firm owned 217,730 shares of the health services provider’s stock after purchasing an additional 4,387 shares during the period. New York State Teachers Retirement System’s holdings in Cigna Group were worth $58,079,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Banco Bilbao Vizcaya Argentaria S.A. increased its stake in shares of Cigna Group by 13.5% during the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after purchasing an additional 4,066 shares in the last quarter. Distillate Capital Partners LLC boosted its position in shares of Cigna Group by 19.1% in the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock worth $31,338,000 after purchasing an additional 17,442 shares in the last quarter. Cooperman Leon G grew its stake in shares of Cigna Group by 53.3% in the 3rd quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock worth $93,681,000 after buying an additional 113,000 shares during the last quarter. Schroder Investment Management Group grew its stake in shares of Cigna Group by 53.0% in the 3rd quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock worth $54,972,000 after buying an additional 66,090 shares during the last quarter. Finally, apricus wealth LLC increased its position in Cigna Group by 715.9% during the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock valued at $2,616,000 after buying an additional 8,340 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on CI shares. Wolfe Research reissued an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Cantor Fitzgerald raised their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a report on Friday, May 1st. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Wells Fargo & Company upped their price target on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Finally, Sanford C. Bernstein increased their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Insider Activity

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Performance

CI stock opened at $287.50 on Friday. The stock’s 50 day simple moving average is $285.09 and its 200 day simple moving average is $279.24. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12-month low of $239.51 and a 12-month high of $323.10. The stock has a market capitalization of $76.05 billion, a PE ratio of 12.19, a price-to-earnings-growth ratio of 1.11 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter last year, the company earned $6.74 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.